合計 50 件の最近のインサイダー取引記録が記録されています Viridian Therapeutics, Inc. (VRDN), 内訳は 31 件の買い および 13 件の売り. インサイダー買い総額は $70.08M インサイダー売り総額は $4.81M.
最近活動のある主要インサイダーには Beetham Thomas W., Mahoney Stephen F., Harmon Seth. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — VRDN
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
RSU 源泉徴収 |
3,138 |
$29.32 |
$92.01K |
13,271 |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
RSU 源泉徴収 |
7,627 |
$29.32 |
$223.62K |
33,130 |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
RSU 源泉徴収 |
2,091 |
$29.32 |
$61.31K |
7,790 |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
RSU 源泉徴収 |
1,724 |
$29.32 |
$50.55K |
3,445 |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
RSU 源泉徴収 |
3,048 |
$30.19 |
$92.02K |
13,361 |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
RSU 源泉徴収 |
7,408 |
$30.19 |
$223.65K |
33,349 |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
RSU 源泉徴収 |
2,031 |
$30.19 |
$61.32K |
7,850 |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
RSU 源泉徴収 |
1,675 |
$30.19 |
$50.57K |
3,494 |
| 2026-03-02 |
Beetham Thomas W. |
Chief Operating Officer |
RSU 付与（制限付株式） |
35,300 |
- |
- |
35,300 |
| 2026-03-02 |
Mahoney Stephen F. |
President and CEO |
RSU 付与（制限付株式） |
111,900 |
- |
- |
111,900 |
| 2026-03-02 |
Tripuraneni Radhika |
Chief Medical Officer |
RSU 付与（制限付株式） |
19,150 |
- |
- |
19,150 |
| 2026-03-02 |
Harmon Seth |
Chief Financial Officer |
RSU 付与（制限付株式） |
20,550 |
- |
- |
20,550 |
| 2026-03-02 |
Tousignant Jennifer |
Chief Legal Officer |
RSU 付与（制限付株式） |
23,850 |
- |
- |
23,850 |
| 2025-12-31 |
Tousignant Jennifer |
Chief Legal Officer |
情報に基づく売り |
2,272 |
$31.16 |
$70.8K |
- |
| 2025-10-23 |
Fairmount Funds Management Llc |
10 Percent Owner |
情報に基づく買い |
454,545 |
$22.00 |
$10M |
3,914,458 |
| 2025-07-01 |
Morris Arlene |
Director |
RSU 付与（制限付株式） |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Ajer Jeffrey Robert |
Director |
RSU 付与（制限付株式） |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Moses Jennifer K. |
Director |
RSU 付与（制限付株式） |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Cain Christopher W. |
Director |
RSU 付与（制限付株式） |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Kiselak Tomas |
Director |
RSU 付与（制限付株式） |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-07-01 |
Gheuens Sarah |
Director |
RSU 付与（制限付株式） |
21,000 |
$14.47 |
$303.87K |
21,000 |
| 2025-06-10 |
Fairmount Funds Management Llc |
10 Percent Owner |
オプション行使（売却） |
12,500 |
$12.31 |
$153.88K |
- |
| 2025-06-09 |
Fairmount Funds Management Llc |
10 Percent Owner |
オプション行使（売却） |
1,600 |
$7.80 |
$12.48K |
- |
| 2025-04-07 |
Ajer Jeffrey Robert |
Officer |
不明 |
- |
- |
- |
- |
| 2025-04-07 |
Ajer Jeffrey Robert |
Director |
RSU 付与（制限付株式） |
42,000 |
$11.78 |
$494.76K |
42,000 |
| 2025-03-10 |
Tripuraneni Radhika |
Chief Medical Officer |
不明 |
40,000 |
$13.21 |
$528.4K |
- |
| 2025-03-10 |
Tripuraneni Radhika |
Chief Medical Officer |
RSU 付与（制限付株式） |
310,700 |
$15.58 |
$4.84M |
310,700 |
| 2025-03-10 |
Cain Christopher W. |
Officer |
不明 |
- |
- |
- |
- |
| 2025-03-10 |
Cain Christopher W. |
Director |
RSU 付与（制限付株式） |
42,000 |
$15.58 |
$654.36K |
42,000 |
| 2025-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
RSU 付与（制限付株式） |
37,636 |
- |
- |
37,636 |
| 2025-03-03 |
Mahoney Stephen F. |
President and CEO |
RSU 付与（制限付株式） |
73,428 |
- |
- |
73,428 |
| 2025-03-03 |
Harmon Seth |
Chief Financial Officer |
RSU 付与（制限付株式） |
25,068 |
- |
- |
25,068 |
| 2025-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
RSU 付与（制限付株式） |
20,679 |
- |
- |
20,679 |
| 2025-03-03 |
Harmon Seth |
Officer |
不明 |
- |
- |
- |
- |
| 2025-03-03 |
Tousignant Jennifer |
Officer |
不明 |
- |
- |
- |
- |
| 2024-09-27 |
Beetham Thomas W. |
Chief Operating Officer |
情報に基づく買い |
5,000 |
$23.41 |
$117.05K |
6,000 |
| 2024-09-27 |
Mahoney Stephen F. |
President and CEO |
情報に基づく買い |
21,400 |
$23.33 |
$499.26K |
21,400 |
| 2024-09-13 |
Fairmount Funds Management Llc |
10 Percent Owner |
情報に基づく買い |
1,600,000 |
$18.75 |
$30M |
3,445,813 |
| 2024-06-26 |
Morris Arlene |
Director |
RSU 付与（制限付株式） |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Harwin Peter Evan |
Director |
RSU 付与（制限付株式） |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Moses Jennifer K. |
Director |
RSU 付与（制限付株式） |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Kiselak Tomas |
Director |
RSU 付与（制限付株式） |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-06-26 |
Gheuens Sarah |
Director |
RSU 付与（制限付株式） |
21,000 |
$12.31 |
$258.51K |
21,000 |
| 2024-03-28 |
Fairmount Funds Management Llc |
10 Percent Owner |
その他（売り） |
5,859 |
- |
- |
- |
| 2024-02-12 |
Tousignant Jennifer |
Officer |
不明 |
- |
- |
- |
- |
| 2024-02-12 |
Tousignant Jennifer |
Chief Legal Officer |
RSU 付与（制限付株式） |
290,000 |
$19.68 |
$5.71M |
290,000 |
| 2024-02-05 |
Ciulla Thomas |
Chief Medical Officer |
RSU 付与（制限付株式） |
50,000 |
$18.70 |
$935K |
50,000 |
| 2024-01-22 |
Fairmount Funds Management Llc |
10 Percent Owner, Other: See Remarks |
情報に基づく買い |
476,190 |
$21.00 |
$10M |
1,839,954 |
| 2024-01-03 |
Ciulla Thomas |
Chief Medical Officer |
処分 |
270,000 |
$13.76 |
$3.72M |
- |
| 2023-11-10 |
Harmon Seth |
See Remarks |
RSU 付与（制限付株式） |
270,000 |
$13.76 |
$3.72M |
270,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
